Under construction – not a live service
Sign in
Taking people in United StatesNo phase

NeuroTechR3 Computer Rehabilitation System for Arm Recovery After Stroke

Tests a computer rehabilitation system to help arm function in adults after stroke.

Plain-language title generated from the registry record
Registry title: Safety and Efficacy of NeuroTechR3 System for Upper Extremity Recovery After Stroke

Key facts

Where
Jacksonville, United StatesSee the site

Where in United States

  • Brooks Rehabilitation Hospital - Bartram CampusJacksonville, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Brooks Rehabilitation
Trial code
NCT07769281
Record updated
17 August 2026
Original description
This research aims to understand the feasibility and effectiveness of using the NeuroTechR3 System to improve upper extremity function after stroke.Read full original descriptionShow less

Safety and Efficacy of NeuroTechR3 System for Upper Extremity Recovery After Stroke

This research aims to understand the feasibility and effectiveness of using the NeuroTechR3 System to improve upper extremity function after stroke.

Inclusion: Age ≥18 years at the time of enrollment; Diagnosed with stroke; No other peripheral or central neurological condition limiting target upper extremity function (previous stroke is ok); Indicated for upper extremity training procedures by participant's treating physician, occupational therapist, or physical therapist; Capable of providing informed consent; Participant demonstrates active extension of wrist and activation of at least two other digits plus thumb activation.

Exclusion: Not independent in functional activities/mobility prior to stroke; Visual impairment that would severely limit ability to see a computer screen for participation in sessions, including severe spatial neglect making the person unable to interact with an entire computer screen; In the opinion of the investigators, the study is not safe or appropriate for the participant, and/or the participant is unlikely to return for the follow-up visits per the protocol to return the device at 4 weeks post discharge; Inability to follow a 3-step motor command; Severe upper extremity tone that will limit participation in study; No internet access at home; Severe receptive aphasia; Severe arthritis that limits hand and arm movements.

ClinicalTrials.gov NCT07769281